艾伯维与印度药企达成协议 获授权血癌新药

格隆汇
Jul 11, 2025

格隆汇7月11日|美国生物制药公司艾伯维与印度药企Glenmark Pharmaceuticals旗下创新研发部门签订授权协议,Glenmark将其研发中针对多发性骨髓瘤(multiple myeloma)的创新药物授权予艾伯维,首期将获支付7亿美元。Glenmark董事总经理Glenn Saldanha透露,公司有机会按研发、监管及商业化进展再获最多12.3亿美元的里程碑款项。药物若日后成功推出...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10